🔎 Trials Near Me

Gara Jalqabaatti › Neuroblastoma › Distaarikii Koloombiyaa

Qorannoo klinikaalii Neuroblastoma Distaarikii Koloombiyaa keessatti

Qorannoo 6 Neuroblastoma f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 30 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06172296

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 23 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07172958

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
18 Months – 40 Years · Saalaa hunda · Haaromfame 12-Hag-2025 · NCT05135975

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.